Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study

19/02/2025
/ Publications
/
VMAT
Survival

Published in the Green Journal, this study from Taiwan compared treatment results of 276 patients with NPC treated with IMPT with a matched cohort of 276...

Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience A

08/06/2021
/ Publications
/
Reirradiation
Survival
Toxicity

A study by the MD Anderson group evaluated the outcomes of 573 patients treated at the institute. Oropharynx (33.3%; n = 191), paranasal sinus (11%; n = 63)...

A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer

08/06/2021
/ Publications
/
IMRT
Survival

This review examined 9 original studies and found that the oncologic outcomes of PBT were similar to IMRT with 2-year local and regional progression-free...

Long-term Outcomes from Proton Therapy for Sinonasal Cancers

08/06/2021
/ Publications
/
Hypofractionation
Chemotherapy
Survival

A study by the Jacksonville group reported clinical outcomes of 143 patients with nonmetastatic sinonasal cancers treated with primary (18%; n = 26) or adjuvant...

Clinical Outcomes of Recurrent Intracranial Meningiomas Treated with Proton Beam Reirradiation.

11/05/2019
/ Publications
/
Reirradiation
Toxicity
Survival

This is a retrospective analysis of 16 patients who received PBRT reRT for recurrent meningiomas. The median PBRT dose was 60 Gy(RBE) and the median follow-up...

Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.

07/07/2016
/ Publications
/
Survival

Based on the national cancer database, there were total of 175,088 patients with HNSCC receiving either photon or proton RT. This analysis pointed out that...

Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.

11/11/2019
/ Publications
/
Toxicity
Survival
Chemotherapy

This study from Taiwan retrospectively examined 30 patients with unresectable CC who were treated with PBT to a total dose of 72.6 GyRBE. The 1-year local...

Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.

11/12/2019
/ Publications
/
Hypofractionation
Survival

This study by MGH retrospectively analyzed 66 patients with unresectable intrahepatic cholangiocarcinoma (ICC) who were treated with hypofractionated proton (32...

Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer.

11/11/2019
/ Publications
/
Chemotherapy
Survival

Published in JAMA, the paper by the UPenn group accessed PBT side effects in the concurrent chemoradiotherapy for locally advanced cancer setting. 1483 adult...

Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer.

01/01/2020
/ Publications
/
Survival

This paper reviews the current status of photon and particle radiation therapy for pancreatic cancer in combination with systemic therapies and hypoxia...